It targets both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors
Trials are investigating obesity, overweight with weight-related conditions, type 2 diabetes, knee osteoarthritis pain, moderate-to-severe obstructive sleep apnea, chronic low back pain, cardiovascular and renal outcomes, and metabolic dysfunction-associated steatotic liver disease
Int J Mol Sci 20(4) Kalkavan H, Green DR (2018) MOMP, cell suicide as a BCL-2 family business [J]
The session highlighted that: Weight loss typically plateaus after an initial period Weight regain commonly occurs after medication discontinuation Repeated cycles of loss and regain raise medical and psychological concerns Focusing solely on short-term weight loss obscures longer-term patterns and may contribute to harm, particularly for individuals vulnerable to eating disorders
Ozempic se aplica mediante una inyeccin subcutnea (debajo de la piel) una vez por semana, siempre el mismo da de la semana, en abdomen, muslo o parte superior del brazo